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Brief Detinitive Report 
TUMORS  INDUCED  BY  MURINE  SARCOMA  VIRUS 
CONTAIN  PRECURSOR  CELLS  CAPABLE  OF  GENERATING 
TUMOR-SPECIFIC  CYTOLYTIC  T  LYMPHOCYTES* 
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The relevance of the immune response in  the development of a  tumor has been 
studied by analyzing the leukocyte infiltration within the tumor mass. Human tumors 
(1), as well as a  number of experimental tumor systems in mice and rats, have been 
analyzed  in  this  manner  (1-8).  Monocytes  and  activated  macrophages  possessing 
cytotoxic and/or cytostatic activities (1-3, 5, 7) and natural killer (NK) cells (4) have 
been  identified  among the  infiltrating  thymus-independent  (i.e.,  non-T)  immune- 
reactive cells which might play a role in tumor rejection. 
In addition  to non-T immune cells, cytolytic thymus-derived lymphocytes (CTL) 
have also been identified among the leukocyte infiltrate of solid tumors (3, 4, 8, 9)  in 
mice. The characterization of CTL, extracted by mechanical and enzymatic proce- 
dures from murine sarcoma virus (MSV)-induced  tumors, indicated that these cyto- 
lyric  cells  consisted  mainly  of small  lymphocytes  (3)  specific  for  MSV-associated 
antigens  (3, 4).  Furthermore,  intra-tumoral CTL were effective only against  tumor 
target cells of the same H-2 haplotype as the effector cells (4). In this report we present 
studies showing that, in addition to active CTL generated in vivo, the T-lymphocyte 
fraction extracted  from MSV-induced  tumors in  C57BL/6  (B6)  mice also contains 
precursor cells capable of differentiating into active CTL when restimulated in vitro. 
These CTL showed a high degree of specificity for virus-associated antigens and their 
cytolytic  activity was  restricted  to  tumor  target  cells  of the  It-2 n  haplotype.  The 
identification of active CTL and of CTL precursor cells within MSV-induced tumors 
points to the existence of a  dynamic state involving T-cell differentiation within the 
tumor mass before the onset of regression. 
Materials and Methods 
Tumors.  MSV tumors were induced in 4-wk-old inbred C57BL/6 (B6, H-2 b) mice bred in 
our own animal colony. Each mouse received a 0.2-ml injection,  intramuscularly into the thigh, 
of a cell-free homogenate containing Moloney routine sarcoma and leukemia virus complex (4, 
10). 
RBL-5 lymphoma cells, induced by Rauscher leukemia virus in B6 mice (H-2 b, 4, 11) were 
51  used both as syngeneic target cells in the  Cr-release assay and as stimulator cells in secondary 
mixed lymphocyte tumor cell cultures (MLTC). Friend erythroleukemia virus-induced HFL/b 
cells  (12) and Gross leukemia virus-induced  B~GV cells  (13), both derived from tumors of 
BALB.B  mice, were also used as H-2 b targets in some cytotoxicity assays. Cultured LSTRA 
* Supported by grant R01 CA 19931 from  the National Institutes of Health. 
:~ Supported by National Institutes of Health Training grant No. 5 T32 CA 09173. 
§ Recipient of a research fellowship from  the Cancer Research Institute, New York. Charg~ de Recherches 
at I.N.S.E.R.M., France. 
J. Exp. MEn. © The Rockefeller  University Press • 0022-1007/79/06/1531/06 $1.00  1531 
Volume 149  June 1979  1531-1536 1532  CHAPDELAINE,  PLATA, AND  LILLY  BRIEF DEFINITIVE REPORT 
tumor cells,  induced by Moloney leukemia  virus in  BALB/c mice (a-2 d,  14)  were used  as 
aliogeneic tumor target cells. Friend, Moloney, and Rauscher leukemia viruses induce strongly 
cross-reacting cellular  antigens,  referred  to collectively as  FMR,  which are,  however, quite 
distinct  from  those  induced  by Gross leukemia  virus  (15).  These  tumor cell  lines  were  all 
maintained as stationary suspension cultures. 
Lymphoid Cells.  The spleen, the inguinal lymph node regional to the MSV-induced tumor 
(RLN)  and  the  mesenteric  lymph  node  (MLN)  were  removed  and  cell  suspensions  were 
• prepared as described elsewhere (16). Leukocytes were extracted from MSV-induced tumors b~ 
a combination of mechanical and enzymatic treatment  (4), with an average yield of 2  ×  10 
leukocytes per tumor. 
Lymphoqyte Cultures.  Syngeneic MLTC were established in 16-mm microweli plates (Costar, 
Data Packaging, Cambridge,  Mass.)  using 5  ×  10  e leukocytes and 0.5  ×  108X-irradiated 
tumor cells  (5,000  rads)  as stimulators  in  2 ml  RPMI-1640 culture medium  (Grand  Island 
Biological Co., Grand Island, N. Y.) containing 5% fetal calf serum (FCS) and 5  ×  10  -5 M  2- 
mercaptoethanol (17). Cells were harvested 6 d later and assayed for cytotoxicity. 
Elimination of T  Cells.  Cell  suspensions  were  depleted  of T  cells  by incubation  with  an 
antiserum prepared by immunizing AKR mice with C3H normal thymus cells  (anti-Thy-l.2 
serum) and rabbit complement (4). 
51Cr-Release Call-Mediated Cytotoxidty Assay.  Cell-mediated anti-tumor cytolytic activity was 
detected using a modification of the method of Brunner et al.  (16). For primary cytotoxic cells 
generated in vivo, varied numbers of lymphoid cells were mixed with  3  ×  10  a 51Cr-labeled 
tumor target cells in a final volume 0.4 ml minimal essential  medium containing 10% FCS and 
10 mM Hepes in 0.5-ml microcentrifuge tubes. After a  19-h incubation at 37°C, the tubes were 
centrifuged at  11,500 g for 30 s, and 0.2 ml of the supernatant  medium was harvested. The 
radioactivity released from the target cells was measured with a well-type gamma scintillation 
counter. 
Lymphocytes harvested from MLTC cultures were assayed for cytolytic activity by incuba- 
tion with  104 5tCr-labeled target cells  at various lymphocyte to target cell  ratios in a 0.2-ml 
total  volume in round-bottomed multi-well  plates  (Linbro Chemical Co.,  Hamden, Conn.). 
After a 6-h incubation at 37°C, the supernates were harvested and measured for radioactivity. 
In all cases, percent specific 51Cr release was calculated by the formula: 
experimental release -- spontaneous release 
maximum release (in 1 N HCI) -  spontaneous release 
X  100. 
Results  and  Discussion 
Adult B6 mice were highly efficient in rejecting tumors induced by MSV.  Under 
our experimental  conditions, tumors became apparent 3-4 d after virus injection and 
reached  diameters  as  large  as  2.5  cm  on  day 9.  Tumor  rejection  occurred  rapidly 
because the tumor mass had completely disappeared  by day  15.  Previous studies of 
the  CTL  response  in  these  mice  showed  that  lymphoid  tissues  including  spleen, 
peripheral  blood, and RLN contained peak CTL numbers on days 8-10, coinciden- 
tally with  maximum  tumor size  (4).  Studies  of the  leukocyte fraction  extracted  by 
mechanical and enzymatic procedures from the tumors of the same mice revealed the 
presence of large numbers of active CTL between days 8 and  10; however, maximum 
CTL  numbers  were  detected  on  day  12,  concurrent  with  the  initiation  of tumor 
regression  (4, 9). 
The experiments  described in the present  communication were designed to detect 
precursor cells capable of differentiating into MSV tumor-specific CITL. B6 mice were 
sacrificed  on  day 8  or 9  after  virus  inoculation  when  they bore  large  tumors,  and 
leukocyte suspensions were prepared from spleen, RLN, MLN, and tumor mass. Each 
leukocyte  suspension  was  assayed  in  a  19-h  51Cr-release  assay  for  the  presence  of 
primary CTL  generated  in  vivo after  tumor  induction;  other portions  of the  same CHAPDELAINE, PLATA, AND LILLY BRIEF DEFINITIVE REPORT  1533 
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FIG.  1.  Lysis  of 5~Cr-labeled RBL-5 target cells by lymphocytes  from B6 mice taken 8 d after 
MSV inoculation.  Activity  of leukocytes  extracted from MSV-induced tumors (O), immune spleen 
(11), RLN (A), MLN (O), and from normal B6 spleens ('R), as detected in a 19-h cytotoxicity  assay. 
(B) Cytolytic  activity generated in vitro after restimulation of the same leukocyte  populations with 
RBL-5 cells (I, A, O, 0, ~r) or normal B6 spleen cells (O, ffl,  A, O), as detected in a 6-h cytotoxicity 
assays. 
leukocyte suspensions were restimulated in culture with syngeneic RBL-5 cells, which 
share tumor antigens in common with MSV-indueed tumor cells (10,  11, 17). 
Fig.  1A shows  that,  in agreement with previous results  (4), leukocytes extracted 
from the tumor mass contained primary cytolytic cells generated in vivo and capable 
of destroying syngeneic RBL-5 target cells to a degree comparable to that of leukocytes 
from the spleen or RLN of the same mice. Under the same experimental conditions, 
spleen  cells  from  normal  B6  mice  did  not  show  detectable  levels  of spontaneous 
cytotoxicity attributable to NK cells. Previous reports (4, 10) have indicated that the 
high degree of cytolytic activity of leukocytes from MSV-immune mice on day 9 is 
mainly a result of thymus-derived effector cells (i.e., CTL). 
The same leukocyte suspensions which yielded high numbers of primary CTL also 
contained  precursor cells  capable  of differentiating into  eytolytic effeetor cells  in 
MLTC. The data summarized  in  Fig.  1 B  indicated that  the leukocytes, recovered 
from  MLTC  after  a  6-d  cultivation,  contained  secondary  cytolytic effeetor cells 
detectable in a 6-h 5XCr-release assay. Leukocytes extracted from the tumor mass were 
capable of generating cytolytic cells comparable in  activity to those  generated by 
leukocytes from RLN or MLN and about three times less  active than effector cells 
generated from spleen cell suspensions. This fact pointed to the existence among these 
leukocyte suspensions of primed MSV-specific CTL precursor cells sensitive to see- 
ondary  stimulation  by  tumor  antigen,  because  parallel  incubation  of normal  B6 
spleen cells with RBL-5 stimulator cells for 6 d yielded 7-times less CTL than cultures 
established with intratumoral  leukocytes, and  ~16 times less CTL than  analogous 
cultures of MSV-immune spleen cells  (Fig.  1 B). Furthermore, incubation of MSV- 
immune lymphocytes in the presence of x-irradiated B6 normal spleen cells (instead 
of RBL-5 cells)  revealed a  residual cytolytic activity on alCr-labeled RBL-5 target 
cells  (Fig.  1 B). This residual cytotoxicity was  3-  to  10-fold lower than  the activity 
generated in secondary MLTC with the same lymphocyte suspensions incubated with 
RBL-5-stimulating cells. The latter observations recall data reported by Gillespie et 
al. (19) in the same tumor system indicating the maturation in vitro of MSV-immune 
CTL precursor cells in the absence of stimulating tumor antigen. 
Cytolytic cells generated in secondary MLTC were specific for antigens induced by 1534  CHAPDELAINE,  PLATA,  AND  LILLY 
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Fla.  2.  Specificity  of effector  cells  generated  in  vitro  by  restimulation  with  RBL-5.  Leukocytes 
from  (A)  the  tumor  mass,  (B)  spleen,  ((3) RLN,  and  (D)  MLN were extracted,  restimulated  in 
secondary MLTC, and assayed after 6 d  for eytolytic activity on 5~Cr-tabeled  RBL-5 (O), LSTRA 
(11), HFL/b (&), and BdGV (0). Aliquots of each effector cell suspension were also pretreated with 
AKR  anti-Thy-l.2  serum  and  complement  (A, O),  then  tested  on  the  same  target  cells  as  the 
untreated suspensions in a 6-h 51Cr release assay. 
leukemia viruses belonging to the FMR group (Fig. 2). Friend virus-induced HFL/b 
(H-2 b)  cells and Rauseher virus-induced  RBL-5 cells were lysed efficiently,  whether 
MLTC  were  initiated  with  leukocytes  from  MSV  tumors,  spleen,  RLN,  or  MLN. 
However,  the same  CTL  did  not  lyse  Gross  virus-induced  BdGV  (H-2 b)  cells  and 
allogeneic Moloney leukemia virus-induced LSTRA (H-2 a) target cells. Other studies 
(18)  have shown that LSTRA cells are highly susceptible to lysis by BALB/c  (H-2 a) 
MVS-immune  CTL, and BdGV cells to lysis by Gross virus-immune BALB.B  CTL 
(13). Thus, B6 eytolytie cells generated in syngeneic secondary MLTC with leukocytes 
from the MSV tumor, the spleen, RLN, or MLN were specific for H-2 b FMR-positive 
tumor target cells.  In addition, Fig.  2 shows that the cytolytic activities detected on 
the  various  tumor  target  cells  were  a  result  of T  lymphocytes.  Incubation  of the 
effector  cell  suspensions  with  AKR  anti-Thy-l.2  serum  and  rabbit  complement 
yielded viable cell suspensions depleted of T  cells and showing very low to undetect- 
able target cell lysis under the same assay conditions. 
Our data indicate that MSV-induced tumors contain CTL precursor cells, as well 
as active CTL generated in vivo during tumor growth. Whether generated in vivo or 
in  vitro,  these  T-killer  cells  had  a  high  degree  of virus  specificity  and  were  H-2 
restricted. These findings point to a possible migration of MSV-specific CTL precursor 
cells between the lymphoid organs and the tumor mass. A similar dynamic flow of T 
cells has been described by Sprent and Miller (20, 21) in another experimental system 
involving allograft rejection by H-2-activated T  lymphocytes from CBA mice. 
Although CTL precursor cells may migrate in mice undergoing tumor rejection, it 
is not known if this is true in mice  bearing progressively  growing tumors. Gillespie 
and collaborators  (9)  showed  that  CTL  could  not be  recovered  from  progressively CHAPDELAINE, PLATA, AND LILLY  BRIEF DEFINITIVE REPORT  1535 
growing MSV-induced tumors, suggesting perhaps that the CTL precursor traffic had 
been radically altered. In agreement with this hypothesis, preliminary experiments in 
our laboratory have indicated that the leukocyte fraction extracted from progressively 
growing  tumors  not  only was  deficient  in  active CTL generated  in  vivo, but  also 
appeared to lack CTL precursor cells. 
Summary 
Leukocyte fractions extracted  from the tumor mass and  the lymphoid organs of 
C57BL/6 (B6) mice carrying murine sarcoma virus-induced tumors contained primed 
cytolytic T-lymphocyte (CTL) precursor cells, in addition to active cytotoxic T  cells. 
These leukocyte fractions gave a  secondary response when stimulated  in  vitro with 
syngeneic tumor cells, generating large numbers of specific CTL. The activity of these 
CTL (H-2~ was apparently H-2-restricted, because it was ineffective on tumor targets 
bearing strongly cross-reacting tumor-specific antigens but with the H-2 d haplotype. 
Furthermore,  only  H-2 b  cells  bearing  the  Friend,  Moloney,  Rauscher-associated 
antigen, such as Rauscher leukemia virus-induced RBL-5 cells and Friend leukemia 
virus-induced HFL/b cells, were lysed efficiently. BdGV cells (H-2 b cells induced by 
Gross leukemia virus) were not affected by the same CTL. We propose the existence 
of a  dynamic state involving the migration of primed CTL precursor cells between 
the  lymphoid  organs  and  the  tumor  mass,  as  well  as  the  differentiation  of these 
precursor cells within the tumor mass into highly specific CTL. 
Received  for publication 20 February 1979. 
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